Home » Generic User-Fee Negotiations to Continue Until End of July
Generic User-Fee Negotiations to Continue Until End of July
Despite “general agreement” on many issues, further discussion is still needed on generic-drug user fees, so the FDA and industry have extended their negotiations until the end of July, according to minutes from a closed-door negotiation meeting held June 9 and made public June 28.
Washington Drug Letter
Washington Drug Letter
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May